Literature DB >> 28003483

Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice.

Junghwa Lee1, Masao Hashimoto1, Se Jin Im1, Koichi Araki1, Hyun-Tak Jin1, Carl W Davis1, Bogumila T Konieczny1, Gregory A Spies2, M Juliana McElrath2, Rafi Ahmed3.   

Abstract

Adenovirus serotype 5 (Ad5) is one of the most widely used viral vectors and is known to generate potent T cell responses. While many previous studies have characterized Ad5-induced CD8 T cell responses, there is a relative lack of detailed studies that have analyzed CD4 T cells elicited by Ad5 vaccination. Here, we immunized mice with Ad5 vectors encoding lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP) and examined GP-specific CD4 T cell responses elicited by Ad5 vectors and compared them to those induced by an acute LCMV infection. In contrast to LCMV infection, where balanced CD4 T helper 1 (Th1) and T follicular helper (Tfh) responses were induced, Ad5 immunization resulted in a significantly reduced frequency of Th1 cells. CD4 T cells elicited by Ad5 vectors expressed decreased levels of Th1 markers, such as Tim3, SLAM, T-bet, and Ly6C, had smaller amounts of cytotoxic molecules like granzyme B, and produced less interferon gamma than CD4 T cells induced by LCMV infection. This defective CD4 Th1 response appeared to be intrinsic for Ad5 vectors and not a reflection of comparing a nonreplicating vector to a live viral infection, since immunization with a DNA vector expressing LCMV-GP generated efficient CD4 Th1 responses. Analysis at early time points (day 3 or 4) after immunization with Ad5 vectors revealed a defect in the expression of CD25 (interleukin-2 [IL-2] receptor alpha chain) on Ad5-elicited CD4 T cells, and administration of exogenous IL-2 following Ad5 immunization partially restored CD4 Th1 responses. These results suggest that impairment of Th1 commitment after Ad5 immunization could be due to reduced IL-2-mediated signaling.IMPORTANCE During viral infection, generating balanced responses of Th1 and Tfh cells is important to induce effective cell-mediated responses and provide optimal help for antibody responses. In this study, to investigate vaccine-induced CD4 T cell responses, we characterized CD4 T cells after immunization with Ad5 vectors expressing LCMV-GP in mice. Ad5 vectors led to altered effector differentiation of LCMV GP-specific CD4 T cells compared to that during LCMV infection. CD4 T cells following Ad5 immunization exhibited impaired Th1 lineage commitment, generating significantly decreased Th1 responses than those induced by LCMV infection. Our results suggest that suboptimal IL-2 signaling possibly plays a role in reduced Th1 development following Ad5 immunization.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  CD4 T cell responses; T follicular helper (Tfh); T helper 1 (Th1); adenovirus serotype 5; vaccination

Mesh:

Substances:

Year:  2017        PMID: 28003483      PMCID: PMC5309930          DOI: 10.1128/JVI.01132-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  T follicular helper cell differentiation, function, and roles in disease.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6.

Authors:  Youn Soo Choi; Robin Kageyama; Danelle Eto; Tania C Escobar; Robert J Johnston; Laurel Monticelli; Christopher Lao; Shane Crotty
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

3.  Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells.

Authors:  Marion Pepper; Antonio J Pagán; Botond Z Igyártó; Justin J Taylor; Marc K Jenkins
Journal:  Immunity       Date:  2011-10-20       Impact factor: 31.745

Review 4.  The role of interleukin-2 during homeostasis and activation of the immune system.

Authors:  Onur Boyman; Jonathan Sprent
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

5.  Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.

Authors:  Nicholas M Provine; Rafael A Larocca; Pablo Penaloza-MacMaster; Erica N Borducchi; Anna McNally; Lily R Parenteau; David R Kaufman; Dan H Barouch
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

6.  Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection.

Authors:  J Scott Hale; Ben Youngblood; Donald R Latner; Ata Ur Rasheed Mohammed; Lilin Ye; Rama S Akondy; Tuoqi Wu; Smita S Iyer; Rafi Ahmed
Journal:  Immunity       Date:  2013-04-11       Impact factor: 31.745

Review 7.  Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

Authors:  Wei Liao; Jian-Xin Lin; Warren J Leonard
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

8.  The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding.

Authors:  Nicolas Fazilleau; Louise J McHeyzer-Williams; Hugh Rosen; Michael G McHeyzer-Williams
Journal:  Nat Immunol       Date:  2009-03-01       Impact factor: 25.606

Review 9.  Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens.

Authors:  Sam Afkhami; Yushi Yao; Zhou Xing
Journal:  Mol Ther Methods Clin Dev       Date:  2016-04-27       Impact factor: 6.698

Review 10.  TCR Signal Strength Alters T-DC Activation and Interaction Times and Directs the Outcome of Differentiation.

Authors:  Nicholas van Panhuys
Journal:  Front Immunol       Date:  2016-01-25       Impact factor: 7.561

View more
  5 in total

1.  Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.

Authors:  Jairo A Fonseca; Jessica N McCaffery; Juan Caceres; Elena Kashentseva; Balwan Singh; Igor P Dmitriev; David T Curiel; Alberto Moreno
Journal:  Vaccine       Date:  2018-04-12       Impact factor: 3.641

2.  Correlates of Follicular Helper Bias in the CD4 T Cell Response to a Retroviral Antigen.

Authors:  Luca Danelli; Tiziano Donnarumma; George Kassiotis
Journal:  Front Immunol       Date:  2018-06-05       Impact factor: 7.561

3.  Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection.

Authors:  Alex S Hartlage; Satyapramod Murthy; Arvind Kumar; Sheetal Trivedi; Piyush Dravid; Himanshu Sharma; Christopher M Walker; Amit Kapoor
Journal:  Nat Commun       Date:  2019-03-07       Impact factor: 14.919

4.  Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats.

Authors:  Alex S Hartlage; Piyush Dravid; Christopher M Walker; Amit Kapoor
Journal:  PLoS Pathog       Date:  2021-03-18       Impact factor: 6.823

Review 5.  Novel Concepts for HIV Vaccine Vector Design.

Authors:  Quazim A Alayo; Nicholas M Provine; Pablo Penaloza-MacMaster
Journal:  mSphere       Date:  2017-12-06       Impact factor: 4.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.